Loading clinical trials...
Loading clinical trials...
Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism:a Prospective Study
To evaluate the effect of anti-hypertensive medication on efficiency of primary aldosteronism screening and confirmatory test, and to determine the appropriate diagnostic cutoff value for Chinese hypertension patients during antihypertensive drugs therapy.
Aldosterone-Renin ratio (ARR)is currently the most reliable means available for screening for primary aldosterone(PA)while captopril challenging test is the widely used confirmatory test. However, some antihypertensive drugs may interfer aldosterone and renin levels. Thus, PA guidelines suggest that antihypertensive drugs should be withdraw or change therapy before screening. But withdraw/changing the therapy is inconvenient for patients. The investigators prepare to start a prospective study through recruiting hypertension patients, completing the ARR screening and captopril challenging test before and after withdraw/change therapy.
Age
10 - 90 years
Sex
ALL
Healthy Volunteers
No
Qifu Li
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Start Date
September 15, 2020
Primary Completion Date
October 31, 2024
Completion Date
October 31, 2024
Last Updated
August 14, 2025
341
ACTUAL participants
withdraw antihypertensive drugs
DIAGNOSTIC_TEST
Lead Sponsor
Chongqing Medical University
NCT02417740
NCT07073820
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07480265